MIAMI BEACH, Fla.
Dec. 21, 2011
/PRNewswire/ -- The team at Divine Skin (OTC Bulletin Board: DSKX) has been working to maintain strong growth and exceed expectations across its diverse consumer goods business and accelerate development through its strong biotechnology program. Some highlights for the year include:
RECORD 2010 REVENUE.
Divine Skin started the year by announcing record sales for 2010 (
or 55 percent over 2009.
RECORD 2011 QUARTERS.
We posted record sales again in Q1 (
) and Q2 (
) of this year, and the first nine-month period (
) was up 74 percent, reaping the benefits of production investments and explosive demand.
In May, DS Laboratories announced new agreements with four distributors that supply 27,000 salons and professionals in the Northwest, Southwest, Southeast, and Midwest.
DS Labs installed more locations of the huge Fantastic Sams chain of salons, supplying unique product, professional training, and promotional assistance.
Prestigious fashion retailer
picked up our super-premium Sigma Skin line for hair and skin.
Top-30 auditing firm Cherry, Bekaert & Holland LLP began advising us, bringing valuable experience with publicly traded manufacturers and lending credibility to financial statements.
A new Brazilian distributor conducted the successful trials and earned the required certificates needed to import into that burgeoning market of 201 million eager consumers.
We announced our foray into pharmaceuticals with an oral analgesic to compete with Tylenol, Advil, and aspirin. Like our other products, it targets the market that appreciates more advanced biotechnology.
Expanding into nutritional supplements, Divine Skin acquired rights to NutraOrigin, with 63 formulas that can be incorporated easily into any health regimen.
We announced a global partnership with
's largest pharmaceutical company, Ranbaxy Laboratories, to sell DS Labs products worldwide.